Rayner will offer the most complete family of trifocal IOLs in the industry, allowing surgeons to treat an even wider range of presbyopic patients: Sulcoflex Trifocal, RayOne Trifocal and new RayOne Trifocal Toric. High patient satisfaction and spectacle independence reported from a multicentre pilot study. RayOne Trifocal Toric’s cylinder range starts from +0.75 D, allowing

12th September 2022. Worthing, United Kingdom. Rayner, the pioneering manufacturer and supplier of ophthalmic solutions for cataract and refractive surgery, today announced the global launch of RayPRO+ at the upcoming ESCRS 2022 congress in Milan. An evolution of RayPRO: Rayner’s proprietary mobile app and web-based digital platform that proactively collects an insightful blend of Patient

Rayner will offer the most complete family of trifocal IOLs in the industry, allowing surgeons to treat an even wider range of presbyopic patients: Sulcoflex Trifocal, RayOne Trifocal and new RayOne Trifocal Toric. High patient satisfaction and spectacle independence reported from a multicentre pilot study. RayOne Trifocal Toric’s cylinder range starts from +0.75 D, allowing

Worthing (UK) – Rayner, the only UK manufacturer of Intraocular Lenses (IOLs) for treating cataracts and last month revealed as a winner of the 2020 Queen’s Awards for Enterprise (Innovation) for its RayOne IOL injector system, announced today that it substantially increased IOL production levels between January and April, despite NHS elective surgery being postponed